Bain Capital Life Sciences Investors as of March 31, 2026
Portfolio Holdings for Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors holds 20 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Heartflow Inc/Sh (HTFL) | 22.9 | $254M | 10M | 24.33 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 21.1 | $234M | 7.3M | 32.01 | |
| Olema Pharmaceuticals (OLMA) | 10.0 | $111M | 7.5M | 14.91 | |
| Savara (SVRA) | 8.7 | $96M | 18M | 5.46 | |
| Pharvaris N V (PHVS) | 6.8 | $76M | 2.7M | 28.25 | |
| Solid Biosciences Com New (SLDB) | 6.4 | $71M | 9.8M | 7.20 | |
| X4 Pharmaceuticals Com New (XFOR) | 3.0 | $33M | 8.0M | 4.13 | |
| Dianthus Therapeutics (DNTH) | 2.7 | $30M | 363k | 83.92 | |
| Annexon (ANNX) | 2.6 | $29M | 5.2M | 5.54 | |
| Kyverna Therapeutics (KYTX) | 2.4 | $27M | 3.1M | 8.63 | |
| Cabaletta Bio (CABA) | 2.3 | $26M | 9.7M | 2.69 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.3 | $25M | 635k | 39.72 | |
| Alkermes SHS (ALKS) | 1.9 | $22M | 610k | 35.36 | |
| Rapid Micro Biosystems Class A Com (RPID) | 1.7 | $19M | 8.4M | 2.27 | |
| C4 Therapeutics Com Stk (CCCC) | 1.7 | $19M | 7.2M | 2.63 | |
| Atea Pharmaceuticals (AVIR) | 1.1 | $13M | 2.4M | 5.38 | |
| Disc Medicine (IRON) | 0.8 | $9.0M | 141k | 63.94 | |
| Upstream Bio (UPB) | 0.7 | $7.8M | 867k | 9.00 | |
| Xilio Therapeutics | 0.5 | $5.6M | 664k | 8.41 | |
| Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW) | 0.2 | $2.0M | 100k | 20.04 |
